Theravance Biopharma, Inc. 3 SEC Filings

Filed On	Filing
16 Feb 2024	Form 3: Miller Aine, SVP, Dev & Head of IRE Office Holds 145,316 shares of Ordinary Shares
26 Dec 2023	Form 3: Grant Jeremy T, Director No securities owned
20 Apr 2023	Form 3: Kelly James Connor, Director No securities owned
28 Feb 2023	Form 3: Gray Susannah, Director No securities owned
22 Feb 2023	Form 3: Grimaud Brett A., SVP, Gen Counsel and Secretary Holds 240,156 shares of Ordinary Shares
10 Jan 2023	Form 3: Sawaf Aziz, SVP & Chief Financial Officer Holds 204,500 shares of Ordinary Shares
21 Oct 2022	Form 3: Samaha Eli, 10% owner Holds 7,012,226 shares of COM
28 Sep 2022	Form 3: Weiss Asset Management Lp, 10% owner and 2 others Holds 7,457,060 shares of Ordinary shares
10 Dec 2021	Form 3: Farnum Rhonda, SVP, Comm & Medical Affairs Holds 319,951 shares of Ordinary Shares
10 Aug 2020	Form 3: Graham Richard A, SVP, Development Holds 114,223 shares of Ordinary Shares
06 Jul 2020	Form 3: Pakianathan Deepika, Director No securities owned
07 Jun 2019	Form 3: Hindman Andrew A., SVP, Chief Financial Officer No securities owned
15 Feb 2019	Form 3: Brady Ann, President, TBIL Holds 77,353 shares of Ordinary Shares
15 Feb 2019	Form 3: Sabesan Vijay, SVP, Technical Operations Holds 154,240 shares of Ordinary Shares
15 Feb 2018	Form 3: Smaldone Alsup Laurie, Director No securities owned
03 Aug 2017	Form 3: Suliman Shehnaaz, SVP, Corp Dev & Strategy No securities owned
09 Mar 2016	Form 3: Pitzer Kenneth R, SVP, Prod Strat & Comm Plng Holds 63,561 shares of Ordinary Shares
09 Mar 2016	Form 3: Hegde Sharathchandra S, SVP, Research Holds 72,165 shares of Ordinary Shares
09 Mar 2016	Form 3: Worboys Philip D, SVP, Translational Science Holds 74,943 shares of Ordinary Shares
23 Oct 2015	Form 3: O'Connor Donal, Director No securities owned

Comments